Patients Professionals Home About us Medicines Research Involvement Vacancies Media You are here: Home > Medicines > Gastroenterology > Cortiment Pentasa Picoprep Glypressin Cortiment Cortiment ® Product: Cortiment Substance name: budesonide Indication: induction of remission in mild to moderately severe active ulcerative colitis Properties Cortiment contains budesonide as active ingredient and thus falls into the drug category of locally acting corticosteroids (adrenal cortex hormones). Cortiment's release profile allows budesonide to be released locally in the colon and rectum. A small part of this (10%) is absorbed into the bloodstream. Cortiment is used in ulcerative colitis, a chronic inflammation of the colon. This disease often starts in the rectum, but the rest of the colon can also become involved. Ulcerative colitis is most common in young adults and middle-aged people. There are approximately 30,000 people in the Netherlands with this condition. Form of administration Cortiment is available in 9 mg tablets and is supplied in boxes of 30 tablets. Package Leaflet Cortiment Summary of Product Characteristics Cortiment (SmPC) Search ABOUT US Who are we What are we doing Transparency Mission and vision History Suppliers Contact MEDICINES For every stage of life Gynecology Gastroenterology endocrinology Urology RESEARCH Ferring Innovation Grants INVOLVEMENT Ferring International Staff members Patient organizations To collaborate VACANCIES Working at Ferring Vacancies Open application Training & Development Ferring BV 2021 © | General Privacy Statement | Pharmacovigilance Privacy Statement | Disclaimer This site is maintained by Ferring BV who is solely responsible for its content.